# 18F-FLUC PET/MR in Patients With Brain Mets

> **NCT06159335** · PHASE3 · RECRUITING · sponsor: **University of Wisconsin, Madison** · enrollment: 30 (estimated)

## Conditions studied

- Brain Metastasis
- Radiation Therapy
- Immunotherapy, Active

## Interventions

- **RADIATION:** F-Fluciclovine radiotracer

## Key facts

- **NCT ID:** NCT06159335
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-10
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06159335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06159335, "18F-FLUC PET/MR in Patients With Brain Mets". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06159335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*